ARTICLE | Company News
GSK in-licenses Apeiron's APN01
February 4, 2010 12:45 AM UTC
Apeiron Biologics AG (Vienna, Austria) granted GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) exclusive, worldwide rights to APN01. The recombinant human angiotensin-converting enzyme 2 (ACE2) is in Phase I ...